Articles On Telix Pharmaceuticals (ASX:TLX)

Telix shares surge as much as 14% after its most advanced cancer therapy candidate passes phase III safety and dosimetry hurdles Clarity says it will achieve the targeted 220 patients for its prostate cancer imaging trial Illinois expansio...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are catching the eye on Tuesday. In morning trade, the radiopharmaceuticals company's shares are up 14% to $11.62. Why are Telix shares jumping? Investors have been bidding the company's shares hi...

So… Oil was up 27% yesterday to ~$116 a barrel. Now down 5% to $86. The S&P futures were down 1.8% last night, and the US market closed up 0.8% this morning. The ASX lost 2.9%, but futures suggest we might make most of that bac...

Good news: The ASX is up 7.4% over the past 12 months, plus probably somewhere around 4% more for dividends. So let's call it a total gain of 11.4%, give or take. That's better than the market's long term average of just over 9% (depending...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Webcast and conference call to be held today, Tuesday March 10 at 9:30 a.m. AEDT...

The Westgold Resources Ltd (ASX: WGX) share price is in focus the company's board approved a $145 million plan to expand the Higginsville Processing Hub, aiming to boost gold output and lower processing costs. What did Westgold Resources re...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company released encouraging Part 1 results from its global Phase 3 ProstACT study of TLX591-Tx, its novel prostate cancer therapy. Key results showed the ther...

The Air New Zealand Ltd (ASX: AIZ) share price is in focus today after the company suspended its FY2026 earnings guidance, citing extreme volatility in global jet fuel markets. The airline previously flagged a first-half loss of $59 million...

The Australian share market suffered one of its worst days in a long time yesterday. At the closing bell of Monday's session, the S&P/ASX 200 Index (ASX: XJO) had crashed 2,85% lower to 8,599 points. That was after closing at 8,851 poin...

The S&P/ASX 200 Index (ASX: XJO) endured another nasty sell-off this Friday, capping off what has been one of the index's worst weeks in years. After dropping heavily on both Tuesday and Wednesday's sessions, the ASX 200 gave up the mod...

Picking Aussie stocks that could surge in the near term is never easy. Markets are influenced by countless factors, and even strong businesses can go through periods where their share prices move sideways. However, from time to time, c...

It was a day of recovery for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Thursday. After enduring two of the worst drops investors have seen in months on Tuesday and yesterday, the ASX 200 rebounded slightly today, rising...

When I think about holding a share for 10 years or more, I'm not asking whether next quarter's result will beat consensus. I'm asking something much simpler. Does this business sit in front of a powerful, long-term trend that is likely t...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin The Future of Prostate Imaging: What do physicians want? MELBOURNE, Australia and...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

February may have included Valentine’s Day, but investors didn’t show a great deal of love for our revenue-generating healthcare stocks Companies producing ambivalent results were whacked while the poor performers were hit even harder But...

If I had $5,000 to deploy into ASX mid-cap shares right now, I'd want businesses that are already executing at scale, but still have meaningful runway ahead of them. Mid-caps are often where I see the most exciting balance of growth and...

Highlights ASX 200 finishes higher as tech stocks extend rebound Ramsay Health Care surges on earnings strength Qantas retreats despite reporting profit beat The ASX 200 closed higher as technology stocks extended gain...

The S&P/ASX 200 Index (ASX: XJO) enjoyed yet another record-breaking session this Thursday, continuing a momentous week for ASX shares and the Australian share market. After launching into positive territory with gusto this morning, the...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin High- and Lowlights from the February results season which is mostly surprising to t...

Highlights Lithium and energy stocks power ahead Tech and insurance shares face heavy pressure ASX 200 closes little changed amid sector rotation The ASX 200 finished largely unchanged as strong gains in lithium and en...

The S&P/ASX 200 Index (ASX: XJO) is trading in the green this morning after finishing 1.84% higher on Friday last week.  The third week of the earnings season saw some sectors soar. ASX 200 tech shares rebounded while strong results...

With just a few days left in February, the ASX remains near record highs. But once again, those highs are being driven by a relatively narrow group of stocks. Away from the banks and major miners, a number of quality names have been sold...

The S&P/ASX 200 Index (ASX: XJO) has historically delivered total returns of around 9% per year over the long term. That is a solid benchmark. But as an active investor, I am always looking for businesses that I believe can outperform t...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke...

CSL Ltd (ASX: CLS) shares have lost 42% in value over 12 months and 12% in 2026.   The global biotech heavyweight — once a market darling — is in a rough stretch. Earlier this month, the ASX biotech posted disappointing half-year r...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have had a tough time over the past 12 months. During this time, the radiopharmaceuticals company's shares have lost 65% of their value. While this is disappointing, Bell Potter believes that it c...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

On Friday, the S&P/ASX 200 Index (ASX: XJO) finished the week with the smallest of declines. The benchmark index edged slightly lower to 9,081.4 points. Will the market be able to bounce back from this on Monday? Here are five things...

Highlights Global tensions weigh on market mood Energy shares gain as oil rises Earnings season drives stock moves Australian equities experienced mixed momentum as geopolitical concerns shaped sentiment, while strong...

The S&P/ASX 200 Index (ASX: XJO) ended its trading week on a sour note this Friday, recording its only loss on what has otherwise been a stellar week for ASX investors. After beginning the day deep in re...

The ASX closed 0.5% lower on Friday but at least it remained up for the week Energy best performing sector on ASX today as oil price rises on Middle East tensions Mixed day of earnings with QBE Insurance and Telix Pharmaceuticals posting s...

The ASX healthcare sector fell 0.73% this week as reporting season continued Pathology and radiology provider Sonic Healthcare rises with H1 results ahead of expectations Morgans lifts its target price for protective gear maker Ansell afte...

Telix Pharmaceuticals Ltd (ASX: TLX) has reported a huge jump in full year revenues while also saying it expects to easily beat that amount in the current year. The drug company said in a statement to the ASX on Friday that full year re...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down slightly to 9,081.3 points. Four ASX shares that are not letting that hold them back are...

highlights Market divergence is reshaping sentiment across key sectors Several well-known names remain under sustained pressure Short positioning reveals where confidence is being tested Short positioning across promin...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have crashed over 21% since the start of 2026 after the company's latest Q4 FY25 results disappointed investors.  The company reported in late January that it had achieved the lower end of it...

Highlights Earnings updates steer ASX market direction Superloop leads gains with strong financial turnaround Technology and financial stocks show notable strength The Australian share market ended on a stronger note a...

Shares in Telix Pharmaceuticals Ltd (ASX: TLX) were trading higher on Wednesday after the company said it had filed a key regulatory approval in Europe. Telix, in a statement to the ASX, said it had submitted a marketing authorisation a...

The TechnologyOne Ltd (ASX: TNE) share price is in focus today after Australia's largest ERP SaaS company lifted its FY26 profit guidance by 5 percentage points, targeting 18% to 20% profit before tax (PBT) growth and 16% to 18% annual recu...

These 2 ASX healthcare shares have had an ordinary start to 2026. Telix Pharmaceuticals Ltd (ASX: TLX) and Neuren Pharmaceuticals Ltd (ASX: NEU) shares have lost 21% and 31% respectively this year so far. However, both ASX healthcare...

The SGH Ltd (ASX: SGH) share price is in focus after the company and Steel Dynamics Inc. confirmed a best and final $32.35 per share offer to acquire BlueScope Steel Ltd (ASX: BSL) valuing BlueScope at $15 billion in cash. The proposal repr...

The Lottery Corporation Ltd (ASX: TLC) share price is in focus today after the company revealed a resilient half-year result for the six months ended 31 December 2025, with group revenue up 2% to $1.82 billion and an 8.0 cent per share full...

Here at The Motley Fool, we are constantly sifting through the noise to find ASX shares that could be undervalued.  Of course, not every down-and-out company is a value. But here are three ASX shares that might have fallen too far t...

The Dexus (ASX: DXS) share price is in focus as the property group delivered a half-year statutory net profit after tax of $348.5 million, up sharply from $10.3 million a year ago, and declared an interim distribution of 19.3 cents per secu...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus as the company announced it has submitted a European marketing authorisation application for TLX101-Px, its brain cancer imaging agent, aiming to widen access to advanced diag...

The Netwealth Group Ltd (ASX: NWL) share price is in focus today after the wealth platform provider posted a 25% lift in revenue to $193.8 million and record custodial inflows of $16.4 billion for the half. What did Netwealth report? Reven...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Feb. 18, 2026 /PRNewswire/ — Telix Pharmac...

The Suncorp Group Ltd (ASX: SUN) share price is in focus today after the company reported first-half FY26 net profit after tax (NPAT) of $263 million, as natural hazard claims surged to $1.3 billion but underlying insurance margins and capi...